The Pediatric Oncology Branch treats a wide variety of pediatric malignancies including acute leukemia, non-Hodgkin's lymphoma, osteogenic sarcoma, rhabdomyosarcoma, Ewing's sarcoma (and other bony or soft-tissue sarcomas), neuroblastoma and brain tumors.

There are over two dozen active treatment protocols. Clinical protocols for newly diagnosed patients emphasize "state of the art" treatment. In addition, treatment approaches for relapsed patients include Phases 1 and 2 studies, which utilize new chemotherapeutic agents and differentiation agents. Children, teenagers and young adults (less than 25 years old) with newly diagnosed or recurrent malignancies are potential candidates for referral to the Pediatric Oncology Branch.

To see the current clinical protocols available, select from among the following:

• NCI POB Bimonthly Report
• New Agents
• Sarcomas
• Brain Tumors
• Neuroblastoma
• NF-1
• Leukemia/Lymphomas
• Antifungal
• Imaging
• Blood and Bone Marrow Stem Cell Transplant
• Psychosocial Support and Research Program

Last Updated: :November 8, 2006

NCI Home Page|| NIH Home Page

© 2002-2003, Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute